Salem Investment Counselors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$173K Hold
815
﹤0.01% 424
2026
Q1
$160K Buy
+815
New +$158K ﹤0.01% 411
2025
Q4
Sell
-553
Closed -$105K 583
2025
Q3
$105K Hold
553
﹤0.01% 460
2025
Q2
$99.3K Hold
553
﹤0.01% 462
2025
Q1
$93.6K Buy
553
+43
+8% +$7.06K ﹤0.01% 463
2024
Q4
$76.9K Hold
510
﹤0.01% 499
2024
Q3
$79.2K Hold
510
﹤0.01% 492
2024
Q2
$69.8K Hold
510
﹤0.01% 503
2024
Q1
$67.9K Hold
510
﹤0.01% 501
2023
Q4
$70.3K Hold
510
﹤0.01% 493
2023
Q3
$62.1K Hold
510
﹤0.01% 494
2023
Q2
$71.7K Hold
510
﹤0.01% 475
2023
Q1
$72.2K Hold
510
﹤0.01% 474
2022
Q4
$79.8K Hold
510
﹤0.01% 447
2022
Q3
$63K Hold
510
﹤0.01% 449
2022
Q2
$68K Sell
510
-71
-12% -$9.68K ﹤0.01% 456
2022
Q1
$80K Sell
581
-51
-8% -$7.11K ﹤0.01% 444
2021
Q4
$109K Buy
632
+492
+351% +$74.9K ﹤0.01% 438
2021
Q3
$20K Hold
140
﹤0.01% 643
2021
Q2
$18K Hold
140
﹤0.01% 637
2021
Q1
$18K Buy
+140
New +$17.3K ﹤0.01% 608
2017
Q3
Sell
-22
Closed -$2K 590
2017
Q2
$2K Buy
+22
New +$2.33K ﹤0.01% 570

Other funds holding DGX

Salem Investment Counselors's DGX Position: Q2 2026 in Review

Salem Investment Counselors held its Quest Diagnostics (DGX) position steady in Q2 2026 at 815 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #424.

Salem Investment Counselors first reported a position in DGX in Q2 2017 and has held it in 22 quarters since. 478 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Salem Investment Counselors held 815 shares of Quest Diagnostics worth $173K as of Q2 2026.
  • Salem Investment Counselors left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #424 holding.
  • Salem Investment Counselors first reported a position in Quest Diagnostics in Q2 2017 and has held it in 22 quarters since.
  • 478 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.